Digital PCR Market

Global digital PCR market is likely to exhibit a promising growth curve as far as the short-term outlook is considered. The report will uncover the insights into how the market growth will unfold in the next few years.

Severing Need for More Efficient Molecular Diagnostic Tools Drives Digital PCR Market

The digital PCR market is expected to rise due to various important causes, including the growing use of digital polymerase chain reaction (dPCR) technique across forensic and research laboratories and the rising demand for advanced diagnostics. The need for prenatal genetic testing techniques is predicted to increase as people become more aware of hereditary diseases such as cystic fibrosis, hemophilia, and thalassemia. Using qPCR and dPCR techniques, fetal DNA present in the mother's blood or the amniotic fluid during the early stages of pregnancy can be examined to find genetic problems before delivery. Then, potential genetic abnormalities and fetuses with defective genes can be treated during the early stages of pregnancy. During the forecast period, the prevalence of infectious and chronic diseases, and genetic disorders is anticipated to rise. The CDC estimates that seven in 10 deaths in the United States occur due to chronic diseases like cancer, diabetes, chronic renal, and respiratory illnesses like asthma. In addition, the prevalence of the congenital cardiac disease is rising, necessitating medical professionals' search for molecular diagnostic tools to make reliable diagnoses. As a result, during the projection period, there will be greater demand for new molecular diagnostic tests due to the rising prevalence of diseases.

Additionally, the introduction of novel technologies and an increase in the number of contract research companies are projected to propel the growth digital PCR market throughout the projection period. The utilization of PCR tests in clinical diagnostics is anticipated to rise as technology improves their sensitivity, accuracy, efficiency, and cost-effectiveness. Furthermore, major industry participants are creating portable, quick, and simple-to-use equipment for use in point-of-care settings. For instance, QuantuMDx announced the introduction of the Q-POC system in July 2021. This system enables quick POC molecular diagnostics that are useful for settings including ICUs, clinics, and birthing facilities. Moreover, many POC polymerase chain reaction diagnostics for detecting COVID-19 disease have been approved in the previous two years.

Digital PCR Market: COVID-19 Impact

The COVID-19 pandemic has significantly impacted the healthcare sector. The diagnostic sector was the most severely affected by the exponential market growth. Digital and real-time PCR have attracted a lot of interest due to their drug development and diagnostics usage. To detect COVID-19, industry providers are concentrating more on developing droplet digital PCR kits. Additionally, many industry participants have developed fresh tools and tests for COVID-19 testing. In September 2020, the SARS-CoV-2 ddPCR Kit from Bio-Rad received Emergency Use Authorization (EUA) from the U.S. FDA to be used to detect SARS-CoV-2 infection. To lessen the effects of the COVID-19 outbreak, regulatory bodies have also stated their strong support for the approval of these tests. It will therefore spur digital PCR market expansion.

Global Digital PCR Market to Gain from Growing Awareness and Acceptance of Personalized Medicines

According to the Individualized Medicine Coalition, there are far more personalized treatments than in 2008, when there were only five such medications (PMC). There are currently more than 145 personalized therapies on the digital PCR market due to growing awareness and acceptance of customized medicines. Additionally, the number of tailored medicines is growing due to the FDA quickly approving new diagnostic procedures and medical procedures that can deliver more effective and efficient healthcare. Diagnostic tests can assist in choosing the most effective course of treatment for each patient.

Perceived Advantages over Conventional RT PCR Strengthen the Case for Digital PCR Market

Instead of the relative measurement obtained from real-time devices, digital polymerase chain reaction helps to offer a comprehensive measure of the target nucleic acid molecules. With the reproducibility, sensitivity, and precision provided by this absolute DNA quantification, researchers can properly assess minor mutations and quantify smaller differences. With the numerous types of genomes in the virus and the extremely low template concentration in the sample, the real-time device chain reaction is not a preferred technique for detecting various parasitic infectious diseases, such as malaria and COVID-19, despite its widespread application. Digital droplet technologies get around these problems and produce precise results with improved group comparisons. These digital devices' numerous advantages over real-time devices are anticipated to support market expansion during the projected period.

High Costs of Digital PCR Devices to Impede Rapid Expansion of Digital PCR Market

Although the digital PCR instrument has many benefits for research applications, its expensive cost deters users from buying it a manual digital PCR instrument costs between US$65,000 and 70,000, but an automated digital PCR device costs US$100,000. Real-time PCR is more expensive than competing methods, costing between US$20,000 and US$30,000. Real-time PCR is much sought after in applications like genotyping and gene expression analysis since it is less expensive than digital PCR, even though dPCR technology is improving. As a result, the high price of digital PCR is stifling the growth digital PCR and leading to a sharp fall in the market.

Clinics to Dominate Digital PCR Market with Better In-patient Treatment Options

In the forecast period, the clinical category had the highest revenue share. This can be attributed to several things, including the rising incidence of diseases like cancer, infectious diseases, and diabetes, high testing precision, increased commercialization of diagnostic reagents, effective disease diagnosis, monitoring, and treatment, and additional advantages in disease detection. There are tests for genetics, infectious disorders, cancer, transplantation, and other conditions that involve nucleic acid amplification under the clinical area. The segment for clinical diagnostics is constantly expanding. This category contributes to a sizable share in digital PCR market thanks to the emergence of molecular diagnostics and disease-specific treatments employed in many hospitals and clinics worldwide.

With Growing Prevalence of Chronic Diseases, Consumables Continue to Lead Digital PCR Market

The consumables and reagents category led the digital PCR market with a major revenue share. It is anticipated that it will continue to dominate during the forecast period. The rising prevalence of infectious and chronic diseases, the rising demand for consumables and reagents used in various diagnostic assay types, and an increase in product introductions all contribute to the segment's growth. Additionally, the substantial segment share is supported by the widespread use of consumables and reagents and the rising demand for healthcare, research, and other uses. Furthermore, it is predicted that the segment will continue to lead during the forecast period. The growing acceptance of technological breakthroughs in the pharmaceutical and healthcare sectors and enhanced research and development would create considerable potential for this market during the expected decade.

North America a Major Revenue Contributor to Global Digital PCR Market

The North American digital PCR market is anticipated to grow at a strong growth rate throughout the forecast period. The population is growing because it is well-informed and steady economically. In addition, it is anticipated that the region will adopt increasingly expensive and technologically sophisticated diagnostics during the projected period. The high prevalence of diseases, the presence of important players in the region, the existence of favorable regulations and numerous initiatives regarding improvements in healthcare infrastructure undertaken by the government, and these factors, all contribute to the growth of the regional market. Another aspect influencing the rise is the increasing patient awareness of the accessibility of contemporary products for successful diagnosis. Additionally, it is anticipated that the substantial presence of well-known manufacturers in the region and the rising demand for rapid diagnostic tests will be key drivers of the North America’s digital PCR market throughout the projected period.

One of the lucrative regions in global digital PCR market is Asia Pacific as it reflects the most lucrative new opportunities for participants. Global players are encouraged to invest in the Asia Pacific region by the untapped potential, significant unmet clinical requirements, and rising healthcare expenditures in the region's member states. Additionally, PCR demand is likely to increase during the projection period due to technological developments and the increased prevalence of several target diseases. For instance, approximately 17 lakh persons in India caught HIV in the past ten years, according to information supplied by the National AIDS Control Organization in April 2022, in response to an RTI inquiry. With the rising occurrence of infectious diseases in the area, there is a greater need for accurate diagnoses, driving the expansion of the digital PCR market in Asia Pacific.

Global Digital PCR Market: Competitive Landscape

In September 2021, Thermo Fisher Scientific, a global leader in science services, announced the introduction of the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to give highly accurate and reproducible results in 90 minutes. The QuantStudio Absolute Q solution's dPCR technology is already in use by biotech corporations and academic institutions for the long-term monitoring of cancer-causing mutations in liquid biopsy. In June 2020, Stilla Technologies, a leading developer of digital PCR (dPCR) solutions for high-precision genetic analysis, introduced the six-color Prism, the world's first digital PCR instrument. The instrument enhances the multiplexing capabilities of the NaicaTM System, the company's digital PCR platform. The equipment has been validated for use with a six-color lung cancer panel for EGFR mutation quantification, liquid-biopsy monitoring in breast and rectal cancer, and detection and quantification of genetically modified organisms in food.

A few of the players in the digital PCR market include Bio-Rad Laboratories, Inc., Agilent Technologies, Thermo Fisher Scientific Inc., Fluidigm Corp, Formulatrix, Inc, JN Medsys, and STILLA.

Regional Classification of the Global Digital PCR Market is Listed Below:

North America

• U.S.
• Canada

Europe

• Germany
• France
• Spain
• U.K.
• Italy
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

 Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East and Africa

• GCC
• South Africa
• Rest of Middle East & Africa

*Regions and countries are subject to change based on data availability.

Key Elements Included In The Study: Global Digital PCR Market

• Digital PCR Market by Product/Technology/Grade, Application/End-user, and Region
• Executive Summary (Opportunity Analysis and Key Trends)
• Historical Market Size and Estimates, Value, 2018 - 2022
• Market Value at Regional and Country Level, 2023 - 2030
• Market Dynamics and Economic Overview
• Market Size in Value, Growth Rates, and Forecast Figures, 2023 - 2030
• Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies 
• Regional and Product/Grade/Application/End-user Price Trends Analysis
• Value Chain and Five Force’s Analysis
• Regional/Sub-region/Country Market Size and Trend Analysis
• Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

• The report will be prepared in a PPT format and will be delivered in a PDF format.

• Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.

• If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.

• If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.

• If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.